Welcome to
Adcock Ingram
Our website offers information about our Company that will give you an understanding of who we are and what we do and how we are building a world class, leading, branded healthcare company. Please contact us should you require any further information on our products or services
to contact us click here
  • Adcock Ingram, a level four B-BBEE pharmaceutical company

  • A leading world-class branded healthcare company

  • Our commitment to quality drives our world-class manufacturing facilities

  • Adding value to life through our Corporate Social Investment programmes

  • Producing pharmaceutical products in the most environmentally friendly way

Latest News

Current News

* SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


* SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


SHOULD YOU invest OVERSEAS?

...ou want to invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. "However, within global markets there is a selection of over 60 pharmaceutical companies, and that's just on the...

read more..


Should you invest overseas

... invest in the pharmaceutical sector of the FTSE/JSE, the options are limited to three companies: Aspen, Ascendis and Adcock Ingram. andldquo;However, within global markets there is a selection of over 60 pharmaceutical companies, and thatandrsquo;s just on the London...

read more..


DA welcomes probe of top pharmaceutical company by Competition Commission

Johannesburg - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would...

read more..


South Africa: Probe of Top Pharmaceutical Company by Competition Commission Welcomed

The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would push up the price o...

read more..


DA welcomes probe of top pharmaceutical company by Competition Commission

Johannesburg - The Competition Commission will conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, the Democratic Alliance said on Sunday. "It is important that any possible anti-competitive behaviour, which would pu...

read more..


DON'T BLAME ATTORNEYS

The Law Society of South Africa (LSSA) voices its serious concern at the allegations made against the attorneys’ profession at last week’s joint sitting of Parliament’s Standing Committee on Appropriations and the Portfolio Committee on Health. The LSSA i...

read more..


Contact Medical Affairs or report an Adverse Event

To contact medical affairs or to report an adverse event
click here

News and Media

For the latest Adcock Ingram news
click here

Careers

For careers that add value to people’s lives
click here

Financial Results

Online Group Audited Results Booklet 2016
click here

Products

For more information on our products
click here

Financial Indicators

Latest Share Price
5939 cents
Percentage Change: 0.00
Code: AIP
PE Ratio: 21.39
EY: 4.68
DY: 1.97
ZAR/USD: 13.0201
Interim Dividend (cents): 54.00
Final Dividend (cents): 63.00
30 day vwap
5997 cents